Frontier Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Frontier Capital Management's RPRX Position: Q3 2026 in Review
Frontier Capital Management held its Royalty Pharma (RPRX) position steady in Q3 2026 at 8,251 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #283.
Frontier Capital Management first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. 702 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Frontier Capital Management held 8,251 shares of Royalty Pharma worth $482K as of Q3 2026.
- Frontier Capital Management left its Royalty Pharma share count unchanged in Q3 2026.
- Royalty Pharma made up 0.01% of Frontier Capital Management's portfolio in Q3 2026, its #283 holding.
- Frontier Capital Management first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
- 702 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Frontier Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.